Table 2. .
Gene |
SNP |
Genotype |
N |
Adjusted for Dietary L and Z and Ancestry* |
Further Adjusted for Waist Circumference, Diabetes, and Fiber Intake |
Final Adjustment for Serum L and Z |
|||||
Mean MPOD |
% Change from Reference |
β† |
P
Value |
β† |
P
Value |
β† |
P
Value |
||||
Xanthophyll binding in retina | |||||||||||
GSTP1 | rs675679 | AA | 1307 | 0.36 | Ref. | 0.028 | 0.033 | 0.027 | 0.035 | 0.027 | 0.031 |
AC | 263 | 0.39 | 8 | ||||||||
CC | 14 | 0.40 | 13 | ||||||||
Carotenoid cleavage | |||||||||||
BCMO1 | rs11645428 | GG | 710 | 0.35 | Ref. | 0.029 | 2.2 × 10−4 | 0.031 | 6.3 × 10−5 | 0.017 | 0.027 |
AG | 694 | 0.36 | 5 | ||||||||
AA | 181 | 0.42 | 20 | ||||||||
rs6564863 | GG | 686 | 0.35 | Ref. | 0.017 | 0.027 | 0.020 | 0.011 | 0.018 | 0.018 | |
AG | 718 | 0.36 | 3 | ||||||||
AA | 176 | 0.40 | 12 | ||||||||
HDL transport or status | |||||||||||
ABCA1 | rs1929841 | AA | 995 | 0.37 | Ref. | −0.020 | 0.029 | −0.024 | 0.007 | −0.022 | 0.011 |
AC | 518 | 0.36 | −2 | ||||||||
CC | 72 | 0.30 | −19 | ||||||||
ABCG5 | rs10179921 | GG | 1426 | 0.37 | Ref. | −0.041 | 0.024 | −0.038 | 0.028 | −0.038 | 0.026 |
AG or AA | 153 | 0.33 | −11 | ||||||||
LIPC | rs6078 | GG | 1480 | 0.37 | Ref. | −0.044 | 0.041 | −0.049 | 0.020 | −0.043 | 0.038 |
AG or AA | 105 | 0.32 | −12 | ||||||||
Lipid and/or carotenoid absorption | |||||||||||
SCARB1 | rs10744182 | AA | 525 | 0.38 | Ref. | −0.021 | 0.005 | −0.021 | 0.004 | −0.020 | 0.005 |
AG | 760 | 0.36 | −5 | ||||||||
GG | 298 | 0.34 | −11 | ||||||||
rs838879 | AA | 768 | 0.38 | Ref. | −0.018 | 0.020 | −0.020 | 0.010 | −0.018 | 0.016 | |
AG | 647 | 0.35 | −7 | ||||||||
GG | 169 | 0.35 | −8 | ||||||||
rs4379922 | AA | 651 | 0.37 | Ref. | −0.016 | 0.036 | −0.019 | 0.010 | −0.016 | 0.025 | |
AG | 711 | 0.36 | −3 | ||||||||
GG | 220 | 0.34 | −10 | ||||||||
Long-chain fatty acid status | |||||||||||
ELOVL2 | rs1150561 | GG | 1407 | 0.36 | Ref. | 0.040 | 0.016 | 0.045 | 0.006 | 0.040 | 0.012 |
AG or AA | 178 | 0.40 | 11 | ||||||||
FADS1 | rs174534 | AA | 711 | 0.35 | Ref. | 0.017 | 0.031 | 0.015 | 0.056 | 0.015 | 0.041 |
AG | 695 | 0.38 | 8 | ||||||||
GG | 177 | 0.37 | 7 | ||||||||
FADS2 | rs2727271 | AA | 1244 | 0.36 | Ref. | 0.024 | 0.050 | 0.019 | 0.113 | 0.017 | 0.136 |
AT | 323 | 0.38 | 7 | ||||||||
TT | 15 | 0.40 | 12 | ||||||||
Genes previously related to maculopathies | |||||||||||
RPE65 | rs4926339 | GG | 556 | 0.34 | Ref. | 0.018 | 0.020 | 0.017 | 0.021 | 0.015 | 0.038 |
AG | 784 | 0.37 | 10 | ||||||||
AA | 244 | 0.37 | 8 | ||||||||
ALDH3A2 | rs8069576 | GG | 495 | 0.38 | Ref. | −0.017 | 0.027 | −0.016 | 0.026 | −0.015 | 0.037 |
AG | 740 | 0.36 | −6 | ||||||||
AA | 290 | 0.35 | −9 |
First two principal components from principal component analysis using 176 ancestry informative markers.
Beta is increase in MPOD per additional minor allele (additive genetic model).